COMT and Parkinson disease: Tolcapone (Tasmar, 3,4-dihydroxy-4′-methyl-5-nitrobenzophenone)is a potent inhibitor of catechol-O-methyltransferase(COMT) approved in the United States and Europe as an adjunct to levodopaand carbidopa for the treatment of Parkinson’s disease.